Baotou Dongbao Bio-Tech Co.,Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 937.89 million compared to CNY 609.82 million a year ago. Revenue was CNY 943.4 million compared to CNY 612.17 million a year ago.

Net income was CNY 109.44 million compared to CNY 36.48 million a year ago. Basic earnings per share from continuing operations was CNY 0.1844 compared to CNY 0.0647 a year ago. Diluted earnings per share from continuing operations was CNY 0.1844 compared to CNY 0.0647 a year ago.